Bevacizumab-Based Chemotherapy and Thrombotic Events Risk in Colorectal Cancer Patients: A Meta-Analysis Study of Randomized Controlled Trials

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.423
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Incidence and Risk of Hypertension With Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis of Randomized Controlled Trials

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-Elderly Patients: Meta-Analysis of Randomized Controlled Trials

Cancer Research and Treatment
Cancer ResearchOncology
2017English

Increased Risk of Cerebrovascular Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Effect of Application and Intensity of Bevacizumab-Based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-Analysis

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Risk of Severe Hematologic Toxicities in Cancer Patients Treated With PARP Inhibitors: A Meta-Analysis of Randomized Controlled Trials

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Statin Use and Risk of Lung Cancer: A Meta-Analysis of Observational Studies and Randomized Controlled Trials

PLoS ONE
Multidisciplinary
2013English

The Addition of Bevacizumab in the First-Line Treatment for Metastatic Colorectal Cancer: An Updated Meta-Analysis of Randomized Trials

Oncotarget
Oncology
2017English

Efficacy and Safety of Raltegravir-Based Dual Therapy in AIDS Patients: A Meta-Analysis of Randomized Controlled Trials

Frontiers in Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy